Therapy Areas: Respiratory
bioMérieux secures IVDR CE marking for respiratory diagnostic panels in Europe
19 March 2026 - French diagnostics company bioMérieux (Euronext Paris:BIM) said on Thursday that it has obtained IVDR CE marking for its BIOFIRE SPOTFIRE Respiratory/Sore Throat plus (R/STplus)...
Avacta opens Phase 1 trial for AVA6103 cancer therapy in US
16 March 2026 - Biopharmaceutical company Avacta Group plc (AIM:AVCT) reported on Monday that it has opened a Phase 1 clinical trial for FAP-Exd (AVA6103), its second pipeline programme and the first ...
ECO Animal Health announces receipt of favourable USDA safety assessment for ECOVAXXIN MG poultry vaccine
11 March 2026 - ECO Animal Health Group plc announced on Wednesday that the United States Department of Agriculture has delivered a favourable safety assessment for its live poultry vaccine ECOVAXXIN ...
IDEAYA Biosciences enrols first patient in Phase 1 trial of PRMT5 inhibitor IDE892
9 March 2026 - Precision medicine oncology company IDEAYA Biosciences Inc (NASDAQ: IDYA) disclosed on Monday that it has enrolled the first patient in a Phase 1 clinical trial evaluating IDE892, an in...
Airiver Medical's Airiver Pulmonary DCB receives US FDA Breakthrough Device Designation
5 March 2026 - Airiver Medical, a clinical stage company developing technologies to help patients who suffer from certain respiratory tract conditions, announced on Wednesday that it has received Brea...
Novartis to build new radioligand therapy site in Texas
...